Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01031056 | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers | withdrawn | — | 0 | Stanford UniversityOTHER | 1 | May 28, 2012 | clinicaltrials |
| NCT00429078 | Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer | withdrawn | Phase 1 | 0 | Roger Williams Medical CenterOTHER | 0 | Mar 2, 2012 | clinicaltrials |
| NCT00622804 |
| Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy |
| withdrawn |
| Phase 3 |
| 90 |
| The Catholic University of KoreaOTHER |
| 1 |
| Aug 3, 2009 |
| clinicaltrials |
| NCT00209612 | Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. | withdrawn | Phase 1 / Phase 2 | 40 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Feb 17, 2009 | clinicaltrials |
Data updated 22 days agoSource updated May 28, 2012source: clinicaltrials